State Administration of Traditional Chinese Medicine of the People's Republic of China
9
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Acupuncture for Pain of Endometriosis
Role: lead
Acupuncture for Ischemic Post-stroke Depression
Role: collaborator
Catgut Implantation at Acupoints for the Treatment of Simple Obesity
Role: collaborator
Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke
Role: collaborator
Acupuncture and Moxibustion for Hyperlipemia
Role: collaborator
Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart Failure
Role: lead
Clinical Trial on the Effectiveness of Herbal Medicinal Mixture in Parkinson Disease
Role: collaborator
A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
Role: collaborator
A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza
Role: collaborator
All 9 trials loaded